US okays protocol for PNT (Pneumatic Trabeculoplasty) glaucoma therapy study:
This article was originally published in Clinica
Executive Summary
Coronado Industries is pressing ahead with efforts to gather data to support a US marketing application for its non-invasive pneumatic device for treating glaucoma, after receiving FDA approval for its study protocol. The Pneumatic Trabeculoplasty (PNT) device, which is already CE-marked for sale in Europe, works by applying suction to the eye for two minutes to reduce intraocular pressure. The Fountain Hills, Arizona firm says it is working with Novartis on an agreement covering exclusive global licensing and distribution rights to the product.